scispace - formally typeset
Search or ask a question
Author

Emily S. Blum

Bio: Emily S. Blum is an academic researcher from Beaumont Hospital. The author has contributed to research in topics: Nocturia & Urinary urgency. The author has an hindex of 1, co-authored 1 publications receiving 20 citations.

Papers
More filters
Journal ArticleDOI
TL;DR: Treatment options focusing on behavioral modification, medical therapy, and neuromodulation are reviewed, remembering that more than one may be needed and can be used concomitantly.
Abstract: Overactive bladder (OAB) is a symptom complex of urinary frequency, nocturia and urgency with or without urgency incontinence that adversely impacts patient’s quality of life. Conservative management begins in the outpatient clinic, often with significant improvement and patient satisfaction. In this review we will discuss the evaluation of OAB and review treatment options focusing on behavioral modification, medical therapy, and neuromodulation. These treatment options are offered in a stepwise fashion, remembering that more than one may be needed and can be used concomitantly.

21 citations


Cited by
More filters
Journal ArticleDOI
TL;DR: The aim of this review is to inform clinicians regarding OAB management in order to improve patient counseling and care.
Abstract: Overactive bladder (OAB) is a common condition affecting millions of men and women worldwide. It is an embarrassing condition with far-reaching consequences. Although many treatment options exist, no single treatment has been proven to be most effective. Often a combination of therapy is required to successfully manage OAB symptoms. In this review, we provide an overview of OAB, including risk factors for development of OAB; keys to diagnosis; therapeutic options including conservative and medical management, as well as treatments for refractory OAB; when to consider referral to a specialist; and resources for clinicians and patients. The aim of this review is to inform clinicians regarding OAB management in order to improve patient counseling and care.

48 citations

Patent
30 May 2014
TL;DR: A topical nerve stimulator patch and system comprising a dermal patch, an electrical signal generator associated with the patch, a signal receiver to activate the generator, and a power source for the generator are described in this paper.
Abstract: A topical nerve stimulator patch and system are provided comprising a dermal patch; an electrical signal generator associated with the patch; a signal receiver to activate the electrical signal generator; a power source for the electrical signal generator associated with the patch; an electrical signal activation device; and a nerve feedback sensor.

33 citations

Journal ArticleDOI
TL;DR: It is demonstrated that transcutaneous spinal cord stimulation (TSCS), a non-invasive intervention, applied over the thoracolumbar spine in neurologically intact rhesus macaques can activate the LUT, including activation of the bladder detrusor muscle, the urethral sphincter and pelvic floor muscles, and enable voiding in select neurological conditions.

20 citations

Journal ArticleDOI
TL;DR: Combination treatment did not have any additional benefits in relation to reducing nocturnal voids in patients with NPU; however, combination therapy is helpful because it increases the maximal bladder capacity and decreases the NPI.
Abstract: Purpose The aims of this study were to investigate the efficacy of combining the systematized behavioral modification program (SBMP) with desmopressin therapy and to compare this with desmopressin monotherapy in the treatment of nocturnal polyuria (NPU).

17 citations

Journal ArticleDOI
TL;DR: The aim of this short commentary is to provide an overview of the effectiveness of neuromodulation therapies and of their impact on quality of life, body image, sexual function, and emotional well-being in patients with OAB.
Abstract: Overactive bladder syndrome (OAB) is defined by the presence of urinary urgency, with or without urge incontinence, usually accompanied by an increase in urinary frequency and nocturia in the absence of urinary tract infections (UTI) or other diseases. The overall prevalence of OAB symptoms in the female population is reported to be 16.6% and increases with advancing age and menopause. The aetiology of OAB is not fully understood and is likely to affect a heterogeneous population of patients due to changes to their central and peripheral nervous systems. Although OAB is frequently associated with female sexual dysfunction (FSD), its real impact on sexual function in women has been evaluated only in a few studies. The first line of treatment for OAB includes behavioural modification and physical therapy, either as monotherapies or in combination. Many patients who have not had success in managing their symptoms with more conservative therapies may decide to resort to third-line treatments for refractory OAB. These treatments include neuromodulation therapies, particularly transvaginal electrical stimulation (TES) and sacral neuromodulation (SN). The aim of this short commentary is to provide an overview of the effectiveness of these treatments and of their impact on quality of life, body image, sexual function, and emotional well-being.

14 citations